High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$4.5M
$4,451,149
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| CRSP |
CRISPR Therapeutics AG
|
CFO
Other
|
2026-01-22 | $1,578,986Large | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -83.8%
|
2026-01-22 | $2,104,965Large | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
Equity Compensation
|
2026-01-06 | $1,335,630Largex4 | M | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -28.5%
|
2026-01-06 | $1,786,636Largex3 | S | Form 4 |
| CRSP |
CRISPR Therapeutics AG
|
CFO
10b5-1 SellΔOwn -12.9%
|
2025-12-22 | $559,549x3 | S | Form 4 |